Is there a common motor dysregulation in sleepwalking and REM sleep behaviour disorder?

Journal of Sleep Research
Mehdi HaridiIsabelle Arnulf

Abstract

This study sought to determine if there is any overlap between the two major non-rapid eye movement and rapid eye movement parasomnias, i.e. sleepwalking/sleep terrors and rapid eye movement sleep behaviour disorder. We assessed adult patients with sleepwalking/sleep terrors using rapid eye movement sleep behaviour disorder screening questionnaires and determined if they had enhanced muscle tone during rapid eye movement sleep. Conversely, we assessed rapid eye movement sleep behaviour disorder patients using the Paris Arousal Disorders Severity Scale and determined if they had more N3 awakenings. The 251 participants included 64 patients with rapid eye movement sleep behaviour disorder (29 with idiopathic rapid eye movement sleep behaviour disorder and 35 with rapid eye movement sleep behaviour disorder associated with Parkinson's disease), 62 patients with sleepwalking/sleep terrors, 66 old healthy controls (age-matched with the rapid eye movement sleep behaviour disorder group) and 59 young healthy controls (age-matched with the sleepwalking/sleep terrors group). They completed the rapid eye movement sleep behaviour disorder screening questionnaire, rapid eye movement sleep behaviour disorder single question and Paris Arousa...Continue Reading

References

Feb 25, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·C ScaglioneUNKNOWN Bologna, Genova, Parma and Pisa Universities group for the study of REM Sleep Behavior Disorder in Parkinson's Disease
Jun 21, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Isabelle ArnulfPhilippe Couratier
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterWolfgang H Oertel
Oct 10, 2007·Archives of Neurology·Rositsa PoryazovaClaudio L Bassetti
Jan 1, 2010·Sleep·Delphine OudietteIsabelle Arnulf
Sep 8, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Jacques MontplaisirJean Paquet
Feb 5, 2011·Journal of Neurology·Michael OberholzerClaudio L Bassetti
Feb 22, 2012·Sleep Medicine·Sushanth BhatDavid Rosen
Mar 27, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Isabelle Arnulf
Jun 1, 2012·Consciousness and Cognition·Delphine OudietteIsabelle Arnulf
Jun 2, 2012·Sleep·Birgit FrauscherUNKNOWN SINBAR (Sleep Innsbruck Barcelona) Group
Jun 26, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaJacques Y Montplaisir
Feb 19, 2013·Lancet Neurology·Antonio ZadraJacques Montplaisir
Sep 24, 2013·Sleep Medicine·B MwengeI Arnulf
Jan 29, 2014·Sleep·Isabelle ArnulfAgnès Brion
Apr 20, 2014·Sleep·Birgit FrauscherBirgit Högl
Jul 25, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Philipp MahlknechtBirgit Högl
Aug 27, 2015·Journal of Sleep Research·Bastien HerlinIsabelle Arnulf

❮ Previous
Next ❯

Citations

Feb 15, 2019·Annals of Neurology·Yaping LiuYun Kwok Wing
May 15, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Aleksandar VidenovicUNKNOWN Treatment and Trials Working Group of the International RBD Study Group
Aug 9, 2019·Annals of Clinical and Translational Neurology·Régis LopezYves Dauvilliers
Aug 29, 2020·Sleep Medicine·A L Rocha, I Arnulf
Sep 20, 2020·Lancet Neurology·Francesca SiclariIsabelle Arnulf
Jun 30, 2021·Sleep Medicine Reviews·Elena AntelmiGiuseppe Plazzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.